CAMBRIDGE, UK, 14th November 2007 -- CellCentric, the biotechnology company unlocking epigenetic control mechanisms, has increased its discovery potential with a new alliance with Prof Tony Kouzarides and Cancer Research Technology Ltd.
CAMBRIDGE, UK, 14th November 2007 -- CellCentric, the biotechnology company unlocking epigenetic control mechanisms, has increased its discovery potential with a new alliance with Prof Tony Kouzarides and Cancer Research Technology Ltd.
